To co-design a feasible intervention that integrates care for patients with multiple long-term conditions (MLTC) into elective surgical pathways, emphasizing the integration of care.
Key Findings:
Current surgical pathways show significant variation and delays in preassessment, limiting the optimization of chronic diseases.
Only 10% of hospitals have MLTC-specific care pathways, primarily focusing on diabetes or anaemia, highlighting a lack of UK guidance on MLTC integration.
A co-designed intervention was developed focusing on diabetes, hypertension, weight management, and smoking cessation.
Interpretation:
The study highlights the need for integrated care models that address the complexities of MLTC in surgical settings, utilizing the surgical waiting period for proactive health management and suggesting implications for healthcare policy.
Limitations:
Limited empirical guidance on operationalizing MLTC-focused surgical care models, particularly in diverse healthcare contexts.
The study's findings are based on a specific context and may not be generalizable to all healthcare systems.
Conclusion:
The co-designed model aims to improve health outcomes by shifting MLTC care upstream to the point of surgical listing, with the next step being practical testing of its effectiveness in real-world settings.
by Sivesh K Kamarajah, Jugdeep Dhesi, Kamlesh Khunti, Krishnarajah Nirantharakumar, Paul Cockwell, Clare Hughes, Paul Stern, Joyce Yeung, Dion G Morton, Aneel A Bhangu, Shalini Ahuja
A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.
Researchers compare personalized versus standard prehabilitation and examine functional, immune, and postoperative outcomes before major elective surgery.
